Suna Orraya, Wattanathorn Jintanaporn, Muchimapura Supaporn, Thukham-Mee Wipawee, Iamsaard Sitthichai, Uabundit Nongnut
Neuroscience Program, Department of Physiology and Graduate School, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Department of Physiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Life (Basel). 2025 Aug 18;15(8):1308. doi: 10.3390/life15081308.
At present, a novel herbal regimen targeting anti-insomnia, anti-anxiety, cognitive performance, and anti-depression effects is required due to the limitations of the current therapy. Based on the crucial role of oxidative stress in the pathophysiology of stress-related brain disorders, it was hypothesized that the functional ingredient derived from mulberry leaves and butterfly pea flowers, which exhibits potent antioxidant activity, should protect against the disorders just mentioned. Male Wistar rats (180-200 g) were orally administered at doses of 125, 250, and 500 mg/kg BW once daily, 45 min before exposure to a 6-h immobilization stress for 14 days. Behavioral assessments, including sleep, anxiety, spatial memory, and depression, were assessed every 7 days. At the end of the study, corticosterone levels, oxidative stress markers, neurotransmitters, IL-6, BDNF, and neuron density in the prefrontal cortex and hippocampus were measured. The functional ingredients demonstrated anti-insomnia, anxiolytic, memory-enhancing, and antidepressant properties. It also increased neuron density and BDNF and activity of SOD and CAT enzymes, whereas corticosterone, GABA-T, AChE, MAO, IL-6, and MDA levels were reduced. A potential regimen targeting showed the benefits of anti-insomnia, anxiolytic, memory-enhancing, and antidepressant properties. However, further studies regarding the precise underlying mechanism and a clinical trial are essentially required.
目前,由于当前疗法存在局限性,需要一种针对抗失眠、抗焦虑、认知能力和抗抑郁作用的新型草药疗法。基于氧化应激在应激相关脑疾病病理生理学中的关键作用,推测从桑叶和蝶豆花中提取的具有强大抗氧化活性的功能成分应能预防上述疾病。雄性Wistar大鼠(180 - 200克)每天一次,在暴露于6小时固定应激前45分钟,按125、250和500毫克/千克体重的剂量口服给药,持续14天。每7天评估包括睡眠、焦虑、空间记忆和抑郁在内的行为。在研究结束时,测量前额叶皮质和海马中的皮质酮水平、氧化应激标志物、神经递质、白细胞介素-6、脑源性神经营养因子(BDNF)和神经元密度。这些功能成分表现出抗失眠、抗焦虑、增强记忆和抗抑郁特性。它还增加了神经元密度和BDNF以及超氧化物歧化酶(SOD)和过氧化氢酶(CAT)的活性,而皮质酮、γ-氨基丁酸转氨酶(GABA-T)、乙酰胆碱酯酶(AChE)、单胺氧化酶(MAO)、白细胞介素-6和丙二醛(MDA)水平降低。一种潜在的靶向疗法显示出抗失眠、抗焦虑、增强记忆和抗抑郁特性的益处。然而,关于确切潜在机制的进一步研究和临床试验是必不可少的。